Apimeds Pharmaceuticals US Inc

APUS | AMEX

$3.00

$0.00 (-0.17%)

Nov 2, 2026, 11:55 AM ET · Market open

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021
Net Income	-6M	-1.39M	-777.69K	-668.67K	-1.03M
Depreciation & Amortization	5.71K	n/a	n/a	n/a	n/a
Stock-Based Compensation	n/a	n/a	69.99K	193.54K	193.54K
Other Working Capital	-2.82M	538.75K	41.84K	-2.18K	2.84K
Other Non-Cash Items	-109.06K	117.72K	38.07K	29.14K	6.74K
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	-2.82M	538.75K	41.84K	-2.18K	2.84K
Operating Cash Flow	-8.93M	-733.53K	-627.79K	-448.17K	-823.11K
Capital Expenditures	-57.33K	n/a	n/a	n/a	n/a
Cash Acquisitions	n/a	n/a	n/a	n/a	n/a
Purchase of Investments	-2M	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	-8M	n/a	n/a	n/a	n/a
Investing Cash Flow	-10.06M	n/a	n/a	n/a	n/a
Debt Repayment	9.3M	250K	n/a	260K	400K
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-314.5K	76.5K	-22.9K	22.9K	n/a
Financial Cash Flow	20.62M	326.5K	1.03M	282.9K	400K
Net Cash Flow	9.63M	-407.03K	404.31K	-165.27K	-423.11K
Free Cash Flow	-8.98M	-733.53K	-627.79K	-448.17K	-823.11K
Adj. Free Cash Flow	-8.98M	-733.53K	-697.78K	-641.71K	-1.02M
Maintenance CapEx	-5.71K	n/a	n/a	n/a	n/a
Growth CapEx	-51.63K	n/a	n/a	n/a	n/a
Owner Earnings	-8.93M	-733.53K	-627.79K	-448.17K	-823.11K